Table 1.
Patient Characteristics Stratified by Hypertension at Baseline
| Characteristic | All Patients (n = 3612) | No Hypertension (n = 3141) | Prevalent Hypertension (n = 471) | P Value |
|---|---|---|---|---|
| Age (y), median (IQR) | 36 (29–44) | 35 (29–42) | 43 (36–49) | <.001 |
| Male sex, n (%) | 2575 (71) | 2269 (72) | 306 (65) | .002 |
| Race/ethnicity, n (%) | .01 | |||
| White, non-Hispanic | 1141 (32) | 1018 (32) | 123 (26) | |
| Black, non-Hispanic | 2133 (59) | 1800 (57) | 333 (71) | |
| Hispanic | 212 (6) | 208 (7) | 4 (1) | |
| Other | 126 (3) | 115 (4) | 11 (2) | |
| Insurance, n (%) | .46 | |||
| Medicare/Medicaid | 1072 (30) | 917 (29) | 155 (33) | |
| Private | 1081 (30) | 940 (29) | 141 (31) | |
| Uninsured | 1519 (42) | 1344 (42) | 175 (36) | |
| Body mass index (kg/m2), Median (IQR) | 23.6 (21.7–25.8) | 23.1 (21.7–25.2) | 25.3 (21.9–28.5) | n/a |
| Serum creatinine (mg/dL) | 0.9 (0.8–1.0) | 0.9 (0.8–1.0) | 1.0 (0.8–1.2) | .03 |
| Ever tobacco use, n (%) | 1495 (41) | 1355 (43) | 140 (30) | <.001 |
| Alcohol abuse, n (%) | 1037 (29) | 926 (29) | 111 (24) | .01 |
| Hyperlipidemia, n (%) | 645 (18) | 518 (16) | 127 (27) | <.001 |
| Diabetes, n (%) | 243 (7) | 167 (5) | 76 (16) | <.001 |
| Hepatitis C, n (%) | 636 (18) | 552 (18) | 84 (18) | .89 |
| ART exposed | 3266 (90) | 2836 (90) | 430 (91) | .49 |
| MSM | 1467 (41) | 1311 (42) | 156 (33) | <.001 |
| IVDU | 488 (14) | 412 (13) | 76 (16) | .07 |
| Cocaine use | 1068 (30) | 943 (30) | 125 (27) | .12 |
| Amphetamine use | 141 (4) | 128 (4) | 13 (3) | .16 |
| CD4 nadir, cells/mm3, median (IQR) | 173 (38–360) | 168 (36–352) | 200 (61–390) | n/a |
All characteristics measured at baseline.
P-values were calculated using Wilcoxon-Mann-Test for continuous variables and Pearson's χ2 for categorical variables.
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range; IVDU, intravenous drug use; MSM, men who have sex with men; n/a, not applicable.